Nelangi M Pinto1, Norman Waitzman2, Richard Nelson3, L LuAnn Minich4, Sergey Krikov5, Lorenzo D Botto5. 1. Division of Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, UT. Electronic address: nelangi.pinto@hsc.utah.edu. 2. Department of Economics, University of Utah, Salt Lake City, UT. 3. Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT. 4. Division of Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, UT. 5. Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT.
Abstract
OBJECTIVE: To assess longitudinal estimates of inpatient costs through early childhood in patients with critical congenital heart defects (CCHDs), for whom reliable estimates are scarce, using a population-based cohort of clinically validated CCHD cases. STUDY DESIGN: Longitudinal retrospective cohort of infants with CCHDs live born from 1997 to 2012 in Utah. Cases identified from birth defect registry data were linked to inpatient discharge abstracts and vital records to track inpatient days and costs through age 10 years. Costs were adjusted for inflation and discounted by 3% per year to generate present value estimates. Multivariable models identified infant and maternal factors potentially associated with higher resource utilization and were used to calculate adjusted costs by defect type. RESULTS: The final statewide cohort included 1439 CCHD cases among 803 509 livebirths (1.8/1000). The average cost per affected child through age 10 years was $136 682 with a median of $74 924 because of a small number of extremely high cost children; costs were highest for pulmonary atresia with ventricular septal defect and hypoplastic left heart syndrome. Inpatient costs increased by 1.6% per year during the study period. A single birth year cohort (~50 000 births/year) had estimated expenditures of $11 902 899 through age 10 years. Extrapolating to the US population, inpatient costs for a single birth year cohort through age 10 years were ~$1 billion. CONCLUSIONS: Inpatient costs for CCHDs throughout childhood are high and rising. These revised estimates will contribute to comparative effectiveness research aimed at improving the value of care on a patient and population level.
OBJECTIVE: To assess longitudinal estimates of inpatient costs through early childhood in patients with critical congenital heart defects (CCHDs), for whom reliable estimates are scarce, using a population-based cohort of clinically validated CCHD cases. STUDY DESIGN: Longitudinal retrospective cohort of infants with CCHDs live born from 1997 to 2012 in Utah. Cases identified from birth defect registry data were linked to inpatient discharge abstracts and vital records to track inpatient days and costs through age 10 years. Costs were adjusted for inflation and discounted by 3% per year to generate present value estimates. Multivariable models identified infant and maternal factors potentially associated with higher resource utilization and were used to calculate adjusted costs by defect type. RESULTS: The final statewide cohort included 1439 CCHD cases among 803 509 livebirths (1.8/1000). The average cost per affected child through age 10 years was $136 682 with a median of $74 924 because of a small number of extremely high cost children; costs were highest for pulmonary atresia with ventricular septal defect and hypoplastic left heart syndrome. Inpatient costs increased by 1.6% per year during the study period. A single birth year cohort (~50 000 births/year) had estimated expenditures of $11 902 899 through age 10 years. Extrapolating to the US population, inpatient costs for a single birth year cohort through age 10 years were ~$1 billion. CONCLUSIONS: Inpatient costs for CCHDs throughout childhood are high and rising. These revised estimates will contribute to comparative effectiveness research aimed at improving the value of care on a patient and population level.
Authors: Kristin Bergman; Nina E Forestieri; Vito L Di Bona; Scott D Grosse; Cynthia A Moore Journal: Birth Defects Res Date: 2022-01-04 Impact factor: 2.661
Authors: Michael L O'Byrne; Andrew C Glatz; Jennifer A Faerber; Roopa Seshadri; Marisa E Millenson; Lanyu Mi; Russell T Shinohara; Yoav Dori; Matthew J Gillespie; Jonathan J Rome; Steven M Kawut; Peter W Groeneveld Journal: J Am Heart Assoc Date: 2019-05-07 Impact factor: 5.501